Echo Therapeutics (NASDAQ: ECTE)

Non-invasive, transdermal, continuous glucose monitoring (CGM) system utilizing a patented skin permeation platform technology that will enable both n....

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Echo Therapeutics (NASDAQ: ECTE) plus 5594 other startups.

Start Free 7 Day Trial Now

Learn More About Echo Therapeutics (NASDAQ: ECTE)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups


Companies We Work With